CN102850411A - 一种d-氨基葡萄糖硫酸氯化钾盐的制备方法 - Google Patents
一种d-氨基葡萄糖硫酸氯化钾盐的制备方法 Download PDFInfo
- Publication number
- CN102850411A CN102850411A CN2012103860320A CN201210386032A CN102850411A CN 102850411 A CN102850411 A CN 102850411A CN 2012103860320 A CN2012103860320 A CN 2012103860320A CN 201210386032 A CN201210386032 A CN 201210386032A CN 102850411 A CN102850411 A CN 102850411A
- Authority
- CN
- China
- Prior art keywords
- glucosamine
- sulfuric acid
- solution
- potassium chloride
- chloride salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- YCHKFNUDARWTSK-FRWAFGSFSA-M potassium;(3r,4r,5s,6r)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol;sulfuric acid;chloride Chemical compound [Cl-].[K+].OS(O)(=O)=O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O YCHKFNUDARWTSK-FRWAFGSFSA-M 0.000 title claims abstract description 86
- 238000002360 preparation method Methods 0.000 title claims abstract description 54
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 87
- MSWZFWKMSRAUBD-UHFFFAOYSA-N 2-Amino-2-Deoxy-Hexose Chemical compound NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims abstract description 62
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 62
- 238000001035 drying Methods 0.000 claims abstract description 61
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 23
- 239000011591 potassium Substances 0.000 claims abstract description 23
- 239000000126 substance Substances 0.000 claims abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims description 89
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 58
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 51
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 49
- 238000001914 filtration Methods 0.000 claims description 40
- 239000007787 solid Substances 0.000 claims description 37
- 239000000706 filtrate Substances 0.000 claims description 36
- -1 second is fine Chemical compound 0.000 claims description 35
- 229910052757 nitrogen Inorganic materials 0.000 claims description 29
- 238000002425 crystallisation Methods 0.000 claims description 28
- 230000008025 crystallization Effects 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 25
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 24
- 235000015320 potassium carbonate Nutrition 0.000 claims description 24
- 238000005507 spraying Methods 0.000 claims description 20
- 239000002904 solvent Substances 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 16
- 229940072033 potash Drugs 0.000 claims description 16
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 16
- 239000007789 gas Substances 0.000 claims description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 7
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 7
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 7
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- 230000000536 complexating effect Effects 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 4
- GHVZOJONCUEWAV-UHFFFAOYSA-N [K].CCO Chemical compound [K].CCO GHVZOJONCUEWAV-UHFFFAOYSA-N 0.000 claims description 4
- 235000011089 carbon dioxide Nutrition 0.000 claims description 4
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 claims description 4
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 3
- 229910052786 argon Inorganic materials 0.000 claims description 3
- 229960001701 chloroform Drugs 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 239000001307 helium Substances 0.000 claims description 3
- 229910052734 helium Inorganic materials 0.000 claims description 3
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 3
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 abstract description 15
- 150000003839 salts Chemical class 0.000 abstract description 7
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 2
- 239000001103 potassium chloride Substances 0.000 abstract description 2
- 235000011164 potassium chloride Nutrition 0.000 abstract description 2
- 238000010668 complexation reaction Methods 0.000 abstract 1
- FGAMKHCTXLHFAL-FRWAFGSFSA-L dipotassium (3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O FGAMKHCTXLHFAL-FRWAFGSFSA-L 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 108
- 241000370738 Chlorion Species 0.000 description 32
- VUEDNLCYHKSELL-UHFFFAOYSA-N arsonium Chemical compound [AsH4+] VUEDNLCYHKSELL-UHFFFAOYSA-N 0.000 description 32
- 229910001385 heavy metal Inorganic materials 0.000 description 32
- 238000004128 high performance liquid chromatography Methods 0.000 description 32
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 32
- 229910052742 iron Inorganic materials 0.000 description 32
- 238000010606 normalization Methods 0.000 description 32
- 230000003287 optical effect Effects 0.000 description 32
- 230000004580 weight loss Effects 0.000 description 32
- 238000001728 nano-filtration Methods 0.000 description 16
- 238000001291 vacuum drying Methods 0.000 description 16
- 239000007864 aqueous solution Substances 0.000 description 13
- 239000012467 final product Substances 0.000 description 11
- 238000001816 cooling Methods 0.000 description 8
- 239000012982 microporous membrane Substances 0.000 description 8
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 230000006837 decompression Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000011593 sulfur Substances 0.000 description 7
- 229910052717 sulfur Inorganic materials 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 235000015497 potassium bicarbonate Nutrition 0.000 description 6
- 239000011736 potassium bicarbonate Substances 0.000 description 6
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 6
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 6
- 206010003246 arthritis Diseases 0.000 description 5
- 239000012266 salt solution Substances 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 4
- 239000008215 water for injection Substances 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- CVCQAQVBOPNTFI-AAONGDSNSA-N (3r,4r,5s,6r)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol;sulfuric acid Chemical compound OS(O)(=O)=O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O CVCQAQVBOPNTFI-AAONGDSNSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 231100001261 hazardous Toxicity 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- VSKBNXJTZZAEPH-NSEZLWDYSA-N (3r,4r,5s,6r)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol;sulfuric acid Chemical compound OS(O)(=O)=O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O VSKBNXJTZZAEPH-NSEZLWDYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 101000748161 Homo sapiens Ubiquitin carboxyl-terminal hydrolase 34 Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010039361 Sacroiliitis Diseases 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 102100040048 Ubiquitin carboxyl-terminal hydrolase 35 Human genes 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000006298 dechlorination reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210386032.0A CN102850411B (zh) | 2012-10-12 | 2012-10-12 | 一种d-氨基葡萄糖硫酸氯化钾盐的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210386032.0A CN102850411B (zh) | 2012-10-12 | 2012-10-12 | 一种d-氨基葡萄糖硫酸氯化钾盐的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102850411A true CN102850411A (zh) | 2013-01-02 |
CN102850411B CN102850411B (zh) | 2015-07-22 |
Family
ID=47397437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210386032.0A Active CN102850411B (zh) | 2012-10-12 | 2012-10-12 | 一种d-氨基葡萄糖硫酸氯化钾盐的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102850411B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103601763A (zh) * | 2013-11-29 | 2014-02-26 | 浙江康多利药业有限公司 | 一种氨基葡萄糖硫酸钾复盐的制备方法 |
CN104710483A (zh) * | 2014-09-11 | 2015-06-17 | 迪沙药业集团有限公司 | 一种硫酸氨基葡萄糖的制备方法 |
CN106589008A (zh) * | 2016-12-20 | 2017-04-26 | 广西大学 | 一种氨基葡萄糖单体的制备方法 |
CN106866751A (zh) * | 2017-02-17 | 2017-06-20 | 江苏双林海洋生物药业有限公司 | 一种硫酸氨基葡萄糖复盐的制备方法 |
CN107827937A (zh) * | 2017-10-27 | 2018-03-23 | 扬州日兴生物科技股份有限公司 | 一种氨基葡萄糖钾盐的制备方法 |
CN110818751A (zh) * | 2019-12-02 | 2020-02-21 | 山东润德生物科技有限公司 | 一种硫酸氨基葡萄糖氯化钠复盐的制备方法 |
CN114853826A (zh) * | 2022-05-12 | 2022-08-05 | 山西辅仁恒峰药业有限公司 | 一种硫酸氨基葡萄糖氯化钠复盐制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5843923A (en) * | 1998-05-22 | 1998-12-01 | Jame Fine Chemicals, Inc. | Glucosamine sulfate potassium chloride and process of preparation thereof |
US6472380B1 (en) * | 1999-11-24 | 2002-10-29 | Jame Fine Chemicals, Inc. | Glucosamine sulfate calcium chloride composition and processes for the preparation of glucosamine sulfate metal chlorides |
JP2010059090A (ja) * | 2008-09-03 | 2010-03-18 | Masao Kikuchi | グルコサミン誘導体の製造方法 |
WO2011054364A1 (en) * | 2009-11-05 | 2011-05-12 | Pharma Base India Pvt. Ltd. | Process for preparing a mixed salt of glucosamine sulfate and a alkali metal chloride |
-
2012
- 2012-10-12 CN CN201210386032.0A patent/CN102850411B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5843923A (en) * | 1998-05-22 | 1998-12-01 | Jame Fine Chemicals, Inc. | Glucosamine sulfate potassium chloride and process of preparation thereof |
US6472380B1 (en) * | 1999-11-24 | 2002-10-29 | Jame Fine Chemicals, Inc. | Glucosamine sulfate calcium chloride composition and processes for the preparation of glucosamine sulfate metal chlorides |
JP2010059090A (ja) * | 2008-09-03 | 2010-03-18 | Masao Kikuchi | グルコサミン誘導体の製造方法 |
WO2011054364A1 (en) * | 2009-11-05 | 2011-05-12 | Pharma Base India Pvt. Ltd. | Process for preparing a mixed salt of glucosamine sulfate and a alkali metal chloride |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103601763A (zh) * | 2013-11-29 | 2014-02-26 | 浙江康多利药业有限公司 | 一种氨基葡萄糖硫酸钾复盐的制备方法 |
CN103601763B (zh) * | 2013-11-29 | 2016-06-08 | 浙江康多利药业有限公司 | 一种氨基葡萄糖硫酸钾复盐的制备方法 |
CN104710483A (zh) * | 2014-09-11 | 2015-06-17 | 迪沙药业集团有限公司 | 一种硫酸氨基葡萄糖的制备方法 |
CN104710483B (zh) * | 2014-09-11 | 2018-12-07 | 迪沙药业集团有限公司 | 一种硫酸氨基葡萄糖的制备方法 |
CN106589008A (zh) * | 2016-12-20 | 2017-04-26 | 广西大学 | 一种氨基葡萄糖单体的制备方法 |
CN106866751A (zh) * | 2017-02-17 | 2017-06-20 | 江苏双林海洋生物药业有限公司 | 一种硫酸氨基葡萄糖复盐的制备方法 |
CN106866751B (zh) * | 2017-02-17 | 2019-11-05 | 江苏双林海洋生物药业有限公司 | 一种硫酸氨基葡萄糖复盐的制备方法 |
CN107827937A (zh) * | 2017-10-27 | 2018-03-23 | 扬州日兴生物科技股份有限公司 | 一种氨基葡萄糖钾盐的制备方法 |
CN110818751A (zh) * | 2019-12-02 | 2020-02-21 | 山东润德生物科技有限公司 | 一种硫酸氨基葡萄糖氯化钠复盐的制备方法 |
CN110818751B (zh) * | 2019-12-02 | 2020-11-10 | 山东润德生物科技有限公司 | 一种硫酸氨基葡萄糖氯化钠复盐的制备方法 |
CN114853826A (zh) * | 2022-05-12 | 2022-08-05 | 山西辅仁恒峰药业有限公司 | 一种硫酸氨基葡萄糖氯化钠复盐制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102850411B (zh) | 2015-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102850411B (zh) | 一种d-氨基葡萄糖硫酸氯化钾盐的制备方法 | |
CN102850412B (zh) | 一种d-氨基葡萄糖硫酸氯化钠盐的制备方法 | |
CN102276663B (zh) | 一种氨基葡萄糖硫酸盐的制备方法 | |
CN103204823B (zh) | 一种1,2-苯并异噻唑-3-酮的提纯方法 | |
CN102295308A (zh) | 一种以含锌废液为原料制备氧化锌的方法 | |
CN106631852A (zh) | 一种从l‑鸟氨酸发酵液中提取l‑鸟氨酸盐酸盐的方法 | |
CN111072492A (zh) | 一种合成3,4-二氯-2-氨基-5-氟联苯的方法 | |
CN106008554A (zh) | 一种头孢曲松钠无菌粉的制备方法及产品 | |
ITMI20060422A1 (it) | Procedimento diretto per la produzione del dicloridrato di un amminoacido | |
CN102219716A (zh) | 一种5-磺基水杨酸的纯化方法 | |
CN102001973A (zh) | 一种1,3—丙二磺酸钠的制备和精制方法 | |
CN106854179A (zh) | 地喹氯铵及其类似物的制备方法 | |
CN101712687B (zh) | 一种盐酸头孢他美酯中间体的制备方法 | |
CN106380453A (zh) | 一种无废水排放的氯代异氰尿酸的工业化生产方法 | |
CN102320990A (zh) | 从盐酸土霉素废液中回收土霉素的方法 | |
CN103755712B (zh) | 一种屠宰场日晒猪血粉中血红素的工业化提取方法 | |
CN104448042B (zh) | 一种壳聚糖硫酸盐的制备方法 | |
CN107628972A (zh) | 一种依卡倍特的三氧化硫卤代烃溶液磺化制备方法 | |
CN105399707B (zh) | 一种制备高纯异抗坏血酸的方法 | |
CN103483232A (zh) | 一种盐酸沃尼妙林的精制方法 | |
CN103172532B (zh) | 一种乙二胺四醋酸钙二钠的制备方法 | |
CN117534638A (zh) | 一种维生素c钙盐的制备方法 | |
CN103172647A (zh) | 一种头孢拉宗钠新晶型及其制备方法 | |
RU2594166C2 (ru) | ЧИСТЫЙ ТЕТРАГИДРАТ L-АРГИНИНОВОЙ СОЛИ S-(-)-9-ФТОР-6, 7-ДИГИДРО-8-(4-ГИДРОКСИПИПЕРИДИН-1-ИЛ)-5-МЕТИЛ-1-ОКСО-1Н, -5Н-БЕНЗО[i,j]ХИНОЛИЗИН-2-КАРБОНОВОЙ КИСЛОТЫ И СПОСОБ ЕГО ПОЛУЧЕНИЯ | |
CN108706621A (zh) | 一种氯化钡生产工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of D-glucosamine sulfate potassium chloride Effective date of registration: 20220520 Granted publication date: 20150722 Pledgee: Bank of Nanjing Co.,Ltd. Lianyungang Branch Pledgor: JIANGSU AOXIN BIOTECHNOLOGY Co.,Ltd. Registration number: Y2022320000242 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230224 Granted publication date: 20150722 Pledgee: Bank of Nanjing Co.,Ltd. Lianyungang Branch Pledgor: JIANGSU AOXIN BIOTECHNOLOGY Co.,Ltd. Registration number: Y2022320000242 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of D-glucosamine sulfate potassium chloride salt Effective date of registration: 20230510 Granted publication date: 20150722 Pledgee: Bank of Nanjing Co.,Ltd. Lianyungang Branch Pledgor: JIANGSU AOXIN BIOTECHNOLOGY Co.,Ltd. Registration number: Y2023320000254 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20150722 Pledgee: Bank of Nanjing Co.,Ltd. Lianyungang Branch Pledgor: JIANGSU AOXIN BIOTECHNOLOGY Co.,Ltd. Registration number: Y2023320000254 |